Osaka, Japan

Nicolas Claude Paul Sax

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Osaka University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicolas Claude Paul Sax. Retrieved from https://idiyas.com/inventor/nicolas-claude-paul-sax

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicolas Claude Paul Sax: Innovator in SARS-CoV-2 Research

Introduction

Nicolas Claude Paul Sax is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of immunology, particularly in relation to the SARS-CoV-2 virus. His innovative work has garnered attention in the scientific community.

Latest Patents

Nicolas Sax holds a patent for "Follicular Helper T (TFH) Cells Specific to SARS-CoV-2 Virus." This patent represents a crucial advancement in understanding the immune response to the virus, potentially paving the way for new therapeutic strategies.

Career Highlights

Sax is affiliated with Osaka University, where he conducts his research. His work focuses on the interactions between the immune system and viral pathogens, contributing to the broader understanding of viral infections.

Collaborations

He collaborates with notable colleagues, including Yuki Hosono and Shigenari Ishizuka. These partnerships enhance the research efforts and foster innovation in their respective fields.

Conclusion

Nicolas Claude Paul Sax is a key figure in the fight against SARS-CoV-2, with his patent and research contributing to the advancement of immunological science. His work exemplifies the importance of innovation in addressing global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…